About Homeobox protein GBX-1
Homeobox protein GBX-1 (GBX1) is a protein
from Homo sapiens identified by UniProt accession
Q14549, 363 residues long.
MolForge cross-references it against 0 known binders and
114 disease associations.
Target properties
| Protein name | Homeobox protein GBX-1 |
| UniProt accession | Q14549 |
| Gene | GBX1 |
| Organism | Homo sapiens |
| Length | 363 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (114)
Diseases linked to this target (Open Targets).
- neurodegenerative disease · score 0.24
- Syndactyly type 2 · score 0.06
- autosomal dominant sensory ataxia 1 · score 0.05
- autosomal recessive spondylocostal dysostosis · score 0.05
- syndactyly type 5 · score 0.05
- mesoaxial synostotic syndactyly with phalangeal reduction · score 0.05
- spondylometaphyseal dysplasia, A4 type · score 0.05
- syndactyly type 4 · score 0.05
- Charcot-Marie-Tooth disease type 1A · score 0.05
- amyotrophic lateral sclerosis · score 0.05
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q14549-F1 | alphafold | PREDICTED | 59.06 | — |
Amino-acid sequence (363 residues)
MQRAGGGSAP GGNGGGGGGG PGTAFSIDSL IGPPPPRSGH LLYTGYPMFM PYRPLVLPQA LAPAPLPAGL PPLAPLASFA GRLTNTFCAG LGQAVPSMVA LTTALPSFAE PPDAFYGPQE LAAAAAAAAA TAARNNPEPG GRRPEGGLEA DELLPAREKV AEPPPPPPPH FSETFPSLPA EGKVYSSDEE KLEASAGDPA GSEQEEEGSG GDSEDDGFLD SSAGGPGALL GPKPKLKGSL GTGAEEGAPV TAGVTAPGGK SRRRRTAFTS EQLLELEKEF HCKKYLSLTE RSQIAHALKL SEVQVKIWFQ NRRAKWKRIK AGNVSSRSGE PVRNPKIVVP IPVHVNRFAV RSQHQQMEQG ARP
Explore Homeobox protein GBX-1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets